(Q44025974)

29 November 2017

title

In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strains (English)

1 reference

29 November 2017

0 references

3

1 reference

29 November 2017

Céline Nicolazzi

1

1 reference

29 November 2017

Véronique Venard

series ordinal

2

1 reference

29 November 2017

Chantal Finance

series ordinal

4

1 reference

29 November 2017

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

54

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

121-127

1 reference

beta-Cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Rapid detection of cytomegalovirus strains resistant to ganciclovir through mutations within the gene UL97.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrug-resistant adenocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Antiviral activity of ganciclovir elaidic acid ester against herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Therapeutic applications of colloidal drug carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Summary of the II International Symposium on Cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Cyclodextrins in peptide and protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: preclinical evaluation of spironolactone bioavailability from solutions of beta-cyclodextrin derivatives in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Cyclodextrins in ophthalmic drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Cyclodextrins in transdermal and rectal delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Effect of the complexation with cyclodextrins on the in vitro antiviral activity of ganciclovir against human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

Ganciclovir. A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

1 reference

7 January 2021

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900218-2

7 January 2021

10.1016/S0166-3542(01)00218-2

Identifiers

DOI

1 reference

29 November 2017

1 reference